Swiss Life Asset Management Ltd reduced its holdings in Cencora, Inc. (NYSE:COR – Free Report) by 6.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 54,039 shares of the company’s stock after selling 3,546 shares during the quarter. Swiss Life Asset Management Ltd’s holdings in Cencora were worth $18,252,000 at the end of the most recent quarter.
A number of other hedge funds have also added to or reduced their stakes in COR. United Bank increased its holdings in Cencora by 4.5% in the second quarter. United Bank now owns 7,032 shares of the company’s stock worth $2,109,000 after purchasing an additional 305 shares in the last quarter. Nebula Research & Development LLC bought a new stake in Cencora in the second quarter worth approximately $595,000. Treasurer of the State of North Carolina increased its holdings in Cencora by 7.9% in the second quarter. Treasurer of the State of North Carolina now owns 85,534 shares of the company’s stock worth $25,647,000 after purchasing an additional 6,244 shares in the last quarter. Diversify Advisory Services LLC increased its holdings in Cencora by 94.1% in the second quarter. Diversify Advisory Services LLC now owns 2,585 shares of the company’s stock worth $747,000 after purchasing an additional 1,253 shares in the last quarter. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main increased its holdings in Cencora by 26.0% in the second quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 73,452 shares of the company’s stock worth $22,025,000 after purchasing an additional 15,154 shares in the last quarter. 97.52% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
A number of equities research analysts have weighed in on COR shares. JPMorgan Chase & Co. lifted their target price on Cencora from $417.00 to $419.00 and gave the stock an “overweight” rating in a report on Tuesday, February 10th. Wells Fargo & Company lowered their target price on Cencora from $429.00 to $331.00 and set an “overweight” rating for the company in a report on Monday. Barclays lifted their target price on Cencora from $400.00 to $425.00 and gave the stock an “overweight” rating in a report on Friday, February 13th. Leerink Partners reiterated an “outperform” rating on shares of Cencora in a report on Tuesday, March 17th. Finally, Evercore set a $360.00 price objective on Cencora in a research note on Wednesday, April 8th. Twelve research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $380.25.
Cencora Trading Down 0.4%
Shares of Cencora stock opened at $259.96 on Tuesday. The company has a debt-to-equity ratio of 3.40, a quick ratio of 0.59 and a current ratio of 0.95. Cencora, Inc. has a 52 week low of $244.82 and a 52 week high of $377.54. The stock has a 50 day moving average price of $323.64 and a two-hundred day moving average price of $341.31. The stock has a market capitalization of $50.57 billion, a PE ratio of 19.94, a price-to-earnings-growth ratio of 1.21 and a beta of 0.64.
Cencora (NYSE:COR – Get Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $4.75 EPS for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). Cencora had a net margin of 0.78% and a return on equity of 135.20%. The firm had revenue of $78.36 billion during the quarter, compared to analyst estimates of $81.09 billion. During the same period last year, the business posted $4.42 EPS. The company’s revenue was up 3.9% on a year-over-year basis. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. As a group, equities analysts anticipate that Cencora, Inc. will post 17.73 earnings per share for the current fiscal year.
Cencora Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 1st. Shareholders of record on Friday, May 15th will be paid a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Friday, May 15th. Cencora’s dividend payout ratio (DPR) is 18.40%.
Cencora Company Profile
Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.
Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.
Featured Stories
- Five stocks we like better than Cencora
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Want to see what other hedge funds are holding COR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cencora, Inc. (NYSE:COR – Free Report).
Receive News & Ratings for Cencora Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cencora and related companies with MarketBeat.com's FREE daily email newsletter.
